JUST IN: Sanofi gets FDA clearance for heart treatment Multaq – The Food and Drug Administration cleared (FDA) Multaq twice-daily 400 mg tablets to reduce the risk of cardiovascular hospitalisation in patients with atrial fibrillation or atrial flutter, Sanofi said on Thursday…more
More JUST IN: Elan and J&J in a joint venture for Alzheimer’s.
Stiffer warnings (black box) for Chantix and Zyban.
Can I sign up for this trip-to-France-clinical-trial? How about a westbound follow-up to Fiji?
More on the Lantus blow-up this week – reporting rushed because of Sanofi stock drop? FDA raising questions about the scary “conclusions.” And what connections to a competitor does a doctor have who rang the alarm bell?
PLUS: Testing drugs for one thing, finding they work for another.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff